Article Data

  • Views 2730
  • Dowloads 234

Original Research

Open Access

Diagnostic accuracy of bedside ultrasonography in COVID-19 suspected patients admitted to the emergency department

  • Ramazan Guven1
  • Ramazan Unal1
  • Burcu Genc Yavuz2
  • Ertugrul Ak1
  • Gokhan Eyupoglu3
  • Salih Fettahoglu1
  • Basar Cander1

1Department of Emergency Medicine, University of Health Sciences, Kanuni Training and Research Hospital, 34303 Istanbul, Turkey

2Department of Emergency Medicine, University of Health Sciences, Haydarpasa Numune Training and Research Hospital, 34668 Istanbul, Turkey

3Department of Emergency Medicine, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Turkey

DOI: 10.22514/sv.2021.116 Vol.18,Issue 1,January 2022 pp.55-61

Submitted: 28 April 2021 Accepted: 01 June 2021

Published: 08 January 2022

*Corresponding Author(s): Ramazan Guven E-mail:


Introduction: Due to the risk of cross contamination and radiation exposure of computed tomography (CT) and low sensitivity rate of X-Ray, point of care ultrasound (POCUS) lung can be used as a diagnostic tool of COVID-19 pneumonia. The current study aimed to evaluate the potential of POCUS for detection of lung pathologies caused by COVID-19.

Methods: This prospective observational study was conducted with 84 patients admitted to the emergency department with suspected COVID-19. CT and POCUS lung were performed for all participants. CCT was taken as the reference diagnostic method and the presence of B-lines or consolidation or pleural irregularity-thickening (>3 mm) in the lung in POCUS lung, were evaluated in favor of COVID-19 pneumonia.

Results: Of the 84 patients included, lesions of COVID-19 pneumonia were detected 53.5%. COVID-19 pneumonia findings were shown by POCUS lung in 51.2% of participants. The left lower lobe in 48.8% and the right lower lobe in 47.6% of the patients were the most commonly affected regions. In POCUS lung, COVID-19 pneumonia lesions located in 2nd area for 44.0%, in 7th area for 35.7%, in 8th area for 34.5%. Sensitivity of POCUS lung was found to be 88.9%, specificity pointed for 92.3%, positive predictive value was 93.0% and negative predictive value was 87.8%.

Conclusion: POCUS lung, has a high sensitivity and specificity in the diagnosis of COVID-19 pneumonia, especially in severe lung involvement. Therefore, POCUS lung should be the method of choice as its practical use, bedside availability and avoidance of radiation exposure for COVID-19 associated lung lesions.


COVID-19; Pneumonia; POCUS lung

Cite and Share

Ramazan Guven,Ramazan Unal,Burcu Genc Yavuz,Ertugrul Ak,Gokhan Eyupoglu,Salih Fettahoglu,Basar Cander. Diagnostic accuracy of bedside ultrasonography in COVID-19 suspected patients admitted to the emergency department. Signa Vitae. 2022. 18(1);55-61.


[1] Li M. Chest CT features and their role in COVID-19. Radiology of Infectious Diseases. 2020; 7: 51–54.

[2] Fiala MJ. A Brief Review of Lung Ultrasonography in COVID-19: is it Useful? Annals of Emergency Medicine. 2020; 75: 784–785.

[3] Lichtenstein DA, Mezière GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008; 134: 117–125.

[4] Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020; 395: 1225–1228.

[5] Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF, et al. Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method. Journal of Ultrasound in Medicine. 2020; 39: 1413–1419.

[6] Scientific Advisory Board Republic of Turkey Ministry of Health. SARS-CoV-2 Infection: general information, epidemiology and diagnosis April 21, 2020. 2020. Available at: https: // (Accessed: 25 May 2020).

[7] Haak SL, Renken IJE, Jager LC, Lameijer H and Kolk BYM. Diagnostic accuracy of point-of-care lung ultrasound in COVID-19. Emergency Medicine Journal. 2021; 38: 94–99.

[8] Fang Y, Zhang H, Xie J, Lin M, Pang P, Ji W. Sensitivity of Chest for COVID-19: Comparison to RT-PCR. Radiology. 2020; 296: E117.

[9] Korkmaz I, Dikmen N, Keles FÖ, Bal T. Chest CT in COVID-19 pnumonia: correlations of imaging findings in clinically suspected but repeatedly RT-PCR test-negative patients. Egyptian Journal of Radiology and Nuclear Medicine. 2021; 52: 96.

[10] Ai T, Yang Z, Hou H, Chenao Z, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020; 296: E32–E40.

[11] Cleverley J, Piper J, Jones MM. The role of chest radiography in confirming covid-19 pneumonia. British Medical Journal. 2020; 370: m2426.

[12] Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. American Journal of Roentgenology. 2020; 214: 1280–1286.

[13] Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: a Multicenter Study. American Journal of Roentgenology. 2020; 214: 1072–1077.

[14] Moore S, Gardiner E. Point of care and intensive care lung ultrasound: a reference guide for practitioners during COVID-19. Radiography. 2020; 26: e297–e302.

[15] Alharthy A, Faqihi F, Abuhamdah M, Noor A, Naseem N, Balhamar A, et al. Prospective Longitudinal Evaluation of Point-of-Care Lung Ultrasound in Critically Ill Patients With Severe COVID-19 Pneumonia. Journal of Ultrasound in Medicine. 2020; 40: 443–456.

[16] Haidan LM, Bingqi ZM, Haiyan KM, Yuanyuan ZM, Keyan LM, Dudu WM, et al. Application Value of Lung Ultrasound in Asymptomatic Patients with Confirmed COVID-19. Advanced Ultrasound in Diagnosis and Therapy. 2020; 4: 67.

[17] Lu W, Zhang S, Chen B, Chen J, Xian J, Lin Y, et al. A Clinical Study of Noninvasive Assessment of Lung Lesions in Patients with Coronavirus Disease-19 (COVID-19) by Bedside Ultrasound. Ultraschall in Der Medizin—European Journal of Ultrasound. 2020; 41: 300–307.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time